Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-01 Purchase |
2024-02-06 10:28 am |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
33,333 | $0.3 | $10,000 | 233,861 (Direct) |
View |
| 2024-02-01 Purchase |
2024-02-06 10:27 am |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
33,333 | $0.3 | $10,000 | 224,313 (Direct) |
View |
| 2024-02-01 Purchase |
2024-02-06 10:27 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
66,666 | $0.3 | $20,000 | 359,916 (Direct) |
View |
| 2024-02-01 Purchase |
2024-02-06 10:27 am |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
166,666 | $0.3 | $50,000 | 836,076 (Direct) |
View |
| 2023-08-22 Purchase |
2023-08-23 08:00 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
27,000 | $1.2658 | $34,177 | 36,772 (Direct) |
View |
| 2023-08-16 Purchase |
2023-08-16 4:01 pm |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
2,750 | $1.798 | $4,945 | 49,010 (Direct) |
View |
| 2022-12-06 Sale |
2023-08-01 5:10 pm |
CNS Pharmaceuticals Inc. | CNSP | Priebe Waldemar 10% Owner |
94,298 | $1.4116 | $133,114 | 156,807 (Indirect) |
View |
| 2023-04-19 Purchase |
2023-04-21 07:58 am |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
2,500 | $1.7 | $4,250 | 9,673 (Direct) |
View |
| 2023-04-17 Purchase |
2023-04-18 08:00 am |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
3,100 | $3.2 | $9,920 | 9,251 (Direct) |
View |
| 2023-04-10 Purchase |
2023-04-17 08:17 am |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
7,173 | $0.74 | $5,308 | 7,173 (Direct) |
View |
| 2023-04-12 Purchase |
2023-04-14 4:20 pm |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
15,000 | $0.6939 | $10,409 | 45,010 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-08-06 4:53 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Cortice Biosciences Inc. 10% Owner |
0 | $0 | 573,368 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:53 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Mahery Amy Director |
35,000 | $0 | 77,340 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:52 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director |
35,000 | $0 | 143,356 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:52 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
35,000 | $0 | 277,188 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:52 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
35,000 | $0 | 276,688 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:51 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
80,000 | $0 | 443 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:51 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director |
35,000 | $0 | 88,648 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:50 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
166,000 | $0 | 1,036,066 (Direct) |
View |
| 2024-04-08 Option Award |
2024-04-10 9:50 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
35,000 | $0 | 112,130 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-06 10:28 am |
N/A 2034-02-01 |
CNS Pharmaceuticals Inc. | CNSP | Mahery Amy Director |
12,420 | $0 | 12,420 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-06 10:28 am |
2024-02-01 2029-02-01 |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
66,666 | $0 | 233,861 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-06 10:27 am |
2024-02-01 2029-02-01 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
66,666 | $0 | 224,313 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-06 10:27 am |
2024-02-01 2029-02-01 |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
133,332 | $0 | 359,916 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-06 10:27 am |
2024-02-01 2029-02-01 |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
333,332 | $0 | 836,076 (Direct) |
View |
| 2023-09-21 Option Award(A) |
2023-10-12 6:01 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
39,475 | $0 | 45,428 (Direct) |
View |
| 2023-09-21 Option Award(A) |
2023-10-12 6:01 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
39,475 | $0 | 45,428 (Direct) |
View |
| 2023-09-21 Option Award(A) |
2023-10-12 6:01 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director |
39,475 | $0 | 45,428 (Direct) |
View |
| 2023-09-14 Option Award(A) |
2023-10-12 6:00 pm |
N/A 2033-09-14 |
CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director |
15,975 | $0 | 26,673 (Direct) |
View |
| 2023-09-21 Option Award(A) |
2023-10-12 6:00 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
26,315 | $0 | 29,815 (Direct) |
View |
| 2023-09-21 Option Award(A) |
2023-10-12 6:00 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director |
39,475 | $0 | 45,428 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 6:27 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director |
68,961 | $0 | 74,914 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 6:26 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director |
68,961 | $0 | 74,914 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 6:24 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
68,961 | $0 | 74,914 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 6:21 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director |
16,551 | $0 | 74,914 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 6:20 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
45,974 | $0 | 74,914 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 6:20 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director |
68,961 | $0 | 74,914 (Direct) |
View |
| 2023-05-05 Option Award(A) |
2023-08-10 9:14 pm |
N/A 2033-05-05 |
CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director |
2,099 | $0 | 2,099 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 5:11 pm |
N/A 2023-05-05 |
CNS Pharmaceuticals Inc. | CNSP | Cockroft Bettina M. Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2023-04-28 Exercise |
2023-05-01 6:59 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Climaco John M Chief Executive Officer |
1,250 | $0 | 106,461 (Direct) |
View |
| 2023-04-28 Exercise |
2023-05-01 6:59 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Downs Christopher Chief Financial Officer |
521 | $0 | 38,020 (Direct) |
View |